Full Programme

Abstract submissions

  • Home
  • Abstract submissions

Call for abstracts: submission information

Abstract submissions open: 10 January 2024 

Submissions Extended deadline: 6 March 2024 at 23:59 Hawaian time

Notification date - extended: 3 May 2024

 

Beyond submission deadline

 

The Global Evidence Summit 2024 extends an open invitation to submit abstracts to be held during the concurrent program. We welcome abstracts related to our Programme Domains and across the domains of health and social sectors. Our inclusive approach encourages participation from all areas within the spheres of: Campbell, Cochrane, JBI, GIN, all programme, partners and other fields of evidence synthesis and guidance development.

We actively seek submissions that tackle global challenges head-on, spotlighting issues of importance. This includes a dedicated focus on evidence synthesis, implementation, methodologies, and the impactful use of evidence to inform decisions. As we advocate for a holistic perspective, we welcome submissions that transcend traditional boundaries, addressing global issues even if they might not be intrinsically linked to health. Our goal is to stimulate discussions that challenge norms and promote innovative solutions to pressing problems.

Your contributions, whether they align with the core Programme Domains or exploring new horizons, will enrich the discourse at the summit, advancing evidence-based practice and contributing to a brighter future for all.

If you have any questions about the relevance of your submission to the programme streams, please contact us: abstracts@globalevidencesummit.org. 

The deadline for submission of abstracts has been extended to 6 March at 23:59 Hawaian time.

Programme domains and concurrent sessions 

We offer seven concurrent sessions designed to accommodate 6 distinct domains, spanning Long Oral, Short Oral, Workshops, Special Sessions, and Moderated Posters.  

1. Sustainable development agenda: how can leading organisations in Evidence-Based Health Care (EBHC)/Education/Social welfare partner and support the delivery of the United Nations Sustainable Development Goals in relation to evidence generation, synthesis and implementation, increasing the value of research and reducing research waste. This might include educational strategies and maximising technological advances.

  • United Nations Sustainable Development Goals and Evidence-Based Health Care (EBHC)/Education/Social Welfare
  • Enhancing evidence generation and synthesis in the context of Sustainable Development Goals
  • Implementing Sustainable Development Goals through evidence
  • Maximizing research value and reducing waste
  • Strategies for education and leveraging technological advances
  • Other Relevant Topics within the Sustainable Development Agenda and evidence realm

2. Research integrity making evidence accessible: including but not limited to the current publishing model, moving to open science, improving quality of peer review (or other approaches); challenges of predatory publishing, research integrity, problematic studies, risk of bias.    

  • Ensuring Research Integrity
  • Challenges within the current publishing model (e.g., Pre-prints, Predatory Publishing)
  • Embracing Open Science
  • Enhancing peer review quality
  • Ensuring accessible evidence for all
  • Impact of artificial intelligence (AI)
  • Diverse aspects of Research Integrity and accessible evidence

3. Power of synergy in evidence synthesis & synthesis products: philosophy of Global Evidence Summit is the collaboration of global leaders in evidence-based policy and practice. Sharing knowledge in methodological innovation and transfer across policy areas. This is not just content (network meta-analysis, clinical study reports) but also the applicability and adaptation of synthesis methods.

  • Collaborative Efforts in Evidence-Based Policy and Practice
  • Advancements in Methodological Innovation
  • Knowledge Sharing and Transfer across Policy Domains
  • Adapting Synthesis Methods for Practical Use
  • Harnessing the Power of Synergy in Evidence Synthesis and Guideline Development
  • Miscellaneous Topics within the Synergy in Evidence Synthesis & Synthesis Products Scope

4. Evidence translation & implementation: knowledge translation, dissemination and implementation strategies including but not limited to guideline development, audit and feedback, leadership and stakeholder engagement strategies. The summit will explore a broad remit of themes and their dependencies, for example, the relationship between the environment (natural and social) and its effects on health, social welfare and wellbeing. 

  • Strategies for Knowledge Translation and Implementation
  • Effective Knowledge Dissemination
  • Guideline Development Strategies
  • Exploring the Impact of Environmental Factors on Health, Social Welfare, and Wellbeing
  • Addressing Equity and Evidence Considerations
  • Leadership and Stakeholder Engagement Approaches
  • Combatting Mistrust in Science
  • Varied Aspects of Evidence Translation & Implementation

5. Advocating for greater evidence communication & use of evidence: including but not limited to systems integration, linked to capacity-building in evidence-synthesis and informing/educating the work of evidence-users; supporting formal educational programmes that lead to certification; advocating for the use of evidence in decision making; and building a ‘climate’ for evidence to increase the use of evidence in policy and practice.

  • Capacity-Building in Evidence Synthesis and Guideline Development
  • Educational Initiatives and Programs
  • Promoting Wider Adoption of Evidence in Decision-Making
  • Creating an Environment Conducive to Evidence Utilization in Policy and Practice
  • Miscellaneous Topics under Advocating for Greater Evidence Communication & Usage

6. From global evidence to local impact: the importance of contextualising evidence, measuring the impact and change evidence has; effective evaluation frameworks measuring impact in ‘improving lives’ through change in practice/outcomes research and development.

  • Bridging Global Evidence to Local Impact, Especially in Low- and Middle-Income Countries (LMICs)
  • The Significance of Contextualizing Evidence
  • Measuring the Impact of Evidence and its Influence on Change
  • Effective Evaluation Frameworks for Enhancing Lives through Research and Practice
  • Various Aspects within the Realm of Global Evidence to Local Impact

How to submit an abstract

To submit an abstract, click on the 'Submit abstract' button at the top or bottom of this page and create your personal account in the submission portal (note: all future communication will be addressed to this registered author). You do not need to register for the Global Evidence Summit 2024 prior to submitting the abstract!

Once logged in, you will be asked to define your contact information first and then you can access the online submission form to submit abstracts for oral or poster presentations. Complete this form and click “Save As Draft” if you still need to edit the abstract or click “Submit” to submit it for review.  If you save your paper as a draft, you can log back in and access your submissions using the “Edit Abstracts” tab in the menu.

Don’t forget to submit your abstract before the extended deadline of 6 March at 23:59 Hawaian time.

Once submitted, you should receive a confirmation email containing a summary of your information.

1. Instructions for oral and poster abstracts

  • Abstracts must be submitted online by extended deadline date: 6 March at 23:59 Hawaian time.
  • Only abstracts submitted in English will be considered.
  • Abstracts must not be more than 350 words.
  • The abstract should follow the structure: Background, Objectives, Methods, Results, Conclusions. If your abstract does not fit into this format, please choose appropriate headings. Please include a statement on the relevance and importance to patients. This may be of direct relevance, or it may be as a contribution to methods that result in more robust evidence production.
  • The abstract title should not be longer than 20 words.
  • Abbreviated terms should be written in full the first time they are used.
  • Tables and graphs can be submitted as an attached image document with your abstract. Allowed formats are: gif, png, jpg, jpeg, tif, tiff,; max. file size is 15 MB; max. size of one image is 1500px. Please remember to insert the reference (Table 1, Figure 1, etc.) in the abstract.
  • You do not need to submit a PDF version of the abstract alongside the form.
  • All accepted abstracts will be copy-edited before being published.
  • Do not include any personal data about specific individuals.

2. Submission of abstracts

You will receive an automated email acknowledging your abstract submission. (Please allow up to 30 minutes to receive this email). If you do not receive an email, or if you require any help with submitting your abstract, please email abstracts@globalevidencesummit.org. 

3. Acceptance and notification of abstracts

Acceptance of abstracts into the conference programme will be determined by the scientific merit, relevance, readability, and clarity, and learning potential of the submitted work.  The philosophy of Global Evidence Summit 2024 is the power of synergy and collaborative effort. This will be an item within the evaluation form.

At the time of submission, you will be asked to indicate a preference for oral or poster presentation; however, the final decision on the type of presentation offered is made by the Abstract subcommittee. Please note that the date to notify authors of acceptance or rejection of their submission has now been postponed from 30 April 2024 and will now be sent out on Friday 3 May 2024.

4. Registration

All presenters of accepted abstracts are required to register and attend the conference. The organizers reserve the right to withdraw abstracts if presenters have not registered and fully paid for the Global Evidence Summit 2024 by 3 June 2024.

For any enquiries about the call for abstracts, please email abstracts@globalevidencesummit.org 

M2ExN